Eubacterium limosum ameliorates experimental colitis and metabolite of microbe attenuates colonic inflammatory action with increase of mucosal integrity

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 7

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

519

HTML

4719

Figures (1-6)

162

Tables (1-2)

128

Sum=5528

Feb 21, 2006 (publication date) through Apr 25, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. Feb 21, 2006; 12(7): 1071-1077
Published online Feb 21, 2006. doi: 10.3748/wjg.v12.i7.1071

Table 2 Organic acid analysis of pooled cecal content in colitis model

Values are the means ± SD of pooled samples analyzed three times.

Citation: Kanauchi O, Fukuda M, Matsumoto Y, Ishii S, Ozawa T, Shimizu M, Mitsuyama K, Andoh A. Eubacterium limosum ameliorates experimental colitis and metabolite of microbe attenuates colonic inflammatory action with increase of mucosal integrity. World J Gastroenterol 2006; 12(7): 1071-1077
URL: https://www.wjgnet.com/1007-9327/full/v12/i7/1071.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i7.1071